CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer

BACKGROUND: Most patients with high-grade serous ovarian cancer (HGSC) lack an effective response to immune checkpoint blockade, highlighting the need for more knowledge about what is required for successful treatment. As follicular cytotoxic CXCR5(+)CD8(+) T cells are maintained by reinvigoration b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Yang, Moran, Lu, Jiaqi, Zhang, Guodong, Wang, Yiying, He, Mengdi, Xu, Qing, Xu, Congjian, Liu, Haiou
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Immunotherapy Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813306/
https://ncbi.nlm.nih.gov/pubmed/33452206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001136
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados